|
|
|
Vol. 12, No. 11, pp. 1610-1620, June 1, 1998
1 Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada; 2 Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada; 3 Center for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada; 4 Department of Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada
| |
Abstract |
|---|
|
|
|---|
SHIP is a 145-kD SH2-containing
inositol-5-phosphatase widely expressed in
hemopoietic cells. It was first identified as a tyrosine phosphoprotein
associated with Shc in response to numerous cytokines. SHIP has been
implicated in Fc
RIIB receptor-mediated negative signaling in B cells
and mast cells and is postulated to down-regulate cytokine signal
transduction in myeloid cells. To define further its role in the
proliferation and differentiation of hemopoietic progenitors, as well
as its function in mature cells, we have generated embryonic stem cells
and mice bearing a targeted disruption of both SHIP alleles.
Here we show that although SHIP null mice are viable and fertile, they
fail to thrive and survival is only 40% by 14 weeks of age. Mortality
is associated with extensive consolidation of the lungs resulting from
infiltration by myeloid cells. Increased numbers of
granulocyte-macrophage progenitors are observed in both the bone
marrow and spleen of SHIP
/
mice, perhaps as a consequence of hyper-responsiveness to stimulation by macrophage-colony stimulating factor, granulocyte-macrophage colony stimulating factor, interleukin-3, or Steel factor as observed in vitro. In contrast, numbers of bone marrow lymphoid and late erythroid progenitors (CFU-E) are reduced. Thus, homozygous disruption of SHIP establishes the crucial role of this molecule in
modulating cytokine signaling within the hemopoietic system and
provides a powerful model for further delineating its function.
[Key Words: SHIP; hemopoiesis; embryonic stem cells; knockout; signal transduction]
| |
Introduction |
|---|
|
|
|---|
SHIP (SH2-containing
inositol-5-phosphatase) is a recently
cloned 145-kD protein that is highly expressed in hemopoietic cells (Damen et al. 1996
; Kavanaugh et al. 1996
; Lioubin et al.
1996
). It contains an amino-terminal src homology 2 (SH2) domain, a central 5'-phosphoinositol phosphatase domain, two
phosphotyrosine binding (PTB) consensus sequences, and a proline-rich
region at the carboxyl tail. SHIP becomes tyrosine phosphorylated
following activation of the hemopoietic cell-surface receptors for
numerous cytokines including erythropoietin (Epo), Steel factor (SF),
interleukin-3 (IL-3) (Cutler et al. 1993
; Damen et al. 1993
), IL-2,
granulocyte-macrophage colony-stimulating factor (GM-CSF), and
macrophage colony stimulating factor (M-CSF) (Lioubin et al. 1994
).
Similarly, cross-linking of the B-cell antigen receptor (Saxton et al.
1994
) or T-cell activation (Ravichandran et al. 1993
) induce SHIP
phosphorylation.
It has been postulated that SHIP may impact on many signal transduction
pathways in hemopoietic cells. For example, SHIP selectively hydrolyzes
the 5'-phosphate from inositol 1,3,4,5-tetraphosphate and
phosphatidylinositol 3,4,5-trisphosphate (PIP3), the
latter being a product of phosphatidylinositol 3'-kinase (PI-3-K)
activity. PI-3-K activation in response to growth factor stimulation is implicated as a major step in mitogenic signaling (Kapeller and Cantley
1994
). In addition, both phosphatidylinositol 3,4-bisphosphate and
PIP3 may play a role in regulating the PKB/Akt
kinase (Marte and Downward 1997
). Interestingly, the catalytic activity
of SHIP is not altered following cytokine stimulation, suggesting that its subcellular localization may be an important regulatory factor (Damen et al. 1996
). In this regard, phosphorylated SHIP has been shown
to associate with Shc (Liu et al. 1997a
), Grb2 (Osborne et al. 1996
),
and the tyrosine phosphatase SHP-2 (Liu et al. 1997b
; Sattler et al.
1997
), which may change its proximity to the membrane and/or various substrates. Furthermore, association with
these molecules suggests that SHIP may function in coupling cytokine receptor activation to the Ras signaling pathway in hemopoietic cells
(Scharenberg and Kinet 1996
; Liu et al. 1997c
; Tridandapani et al.
1997
). Thus, SHIP may regulate the proliferation and differentiation of
hemopoietic cells by modulating PIP3 levels and Ras activity following cytokine stimulation.
SHIP has been implicated in the negative signaling pathways that
abrogate activation in cells of the immune system. Coligation of the
low-affinity Fc receptor for immunoglobulin G (IgG) (Fc
RIIB) with
the B-cell receptor (BCR) or the high-affinity mast cell IgE receptor
(Fc
RI) blocks the influx of extracellular calcium with minimal
effects on the release of calcium from intracellular stores. This
perturbation of calcium signaling may mediate the negative signals on
B-cell growth and mast-cell degranulation. Studies with both mast and B
cells derived from mice deficient in SHP-1
(me/me) suggest that SHIP is the primary
mediator of inhibitory Fc
RIIB signaling (Ono et al. 1996
; Nadler
et al. 1997
). It is unclear however whether SHIP is an inhibitor of
cytokine signal transduction pathways regulating the proliferation and differentiation of other hemopoietic progenitors. Ectopic expression of
SHIP in the FDC-P1 cell line significantly reduces M-CSF-dependent growth (Lioubin et al. 1996
) and increases apoptosis in the DA-ER murine hemopoietic cell line (Liu et al. 1997a
). These observations suggest
that SHIP may down-regulate signals required for survival and proliferation.
Targeted disruption using homologous recombination in embryonic stem
(ES) cells was carried out to further define the role of SHIP in the
proliferation and differentiation of hemopoietic progenitors, as well
as its function in mature cells. The data presented suggest that SHIP
plays an important role in down-regulating the mitogenic signals
initiated through stimulation of numerous growth factor receptors.
Absence of SHIP results in a myeloproliferative-like syndrome and
consolidation of the lungs by infiltration of macrophages, with a consequent
decrease in the survival of SHIP
/
mice.
| |
Results |
|---|
|
|
|---|
Targeted disruption of SHIP
To examine the in vivo function of SHIP, targeted disruption of
the murine SHIP gene was achieved using a strategy in which the entire 254-bp coding sequence of the first exon was replaced with
the neomycin resistance gene in the antisense orientation using either
of the two targeting vectors described in Figure 1A.
Two lines of SHIP knockout mice, one generated with each
targeting vector, were derived using standard techniques. Southern blot analysis of genomic DNA from both the targeted ES cells and
representative F2 mice using a 2-kb
KpnI-HindIII genomic probe confirmed the expected
targeting event (Fig. 1B). Western blot analysis of hemopoietic cells
derived from the in vitro differentiation of SHIP wild type (+/+), heterozygous (+/
), and
null (
/
) R1 ES cells, as well as bone marrow
cells derived from mice of each genotype, confirmed the absence of
full-length or truncated protein products in the SHIP
/
cells (Fig. 1C).
|
SHIP
/
mice fail to
thrive and have profound splenomegaly
Wild-type, heterozygous, and null F2 progeny were
present at the expected Mendelian ratio of 1:2:1
(n = 360). Although both male and female
SHIP
/
mice were viable and
fertile, they failed to thrive and exhibited a 17% reduction in body
weight at 4-5 weeks of age with a further 5% decrease by 8-10 weeks
of age (Table 1). Splenomegaly was also a striking
feature in SHIP
/
mice of
both age groups, with nucleated cell counts increased two- to threefold
above +/+ and +/
littermate
controls. Total spleen cellularity (red + white cells) and weights
were increased five- to sevenfold in the 8-10-week-old knockout
animals (not shown). In contrast, the bone marrow of SHIP null mice
became progressively hypocellular with age (Table 1). The cellularity of the thymus and lymph nodes obtained from
SHIP
/
mice in these two age
groups was highly variable and therefore the differences compared with
the +/+ mice were not significant. In all cases the
phenotype of the +/
mice more closely resembled that of the wild-type mice.
|
SHIP
/
mice have a
shortened life span associated with massive myeloid cell infiltration
of the lungs
Homozygous knockout mice became moribund as early as 4 weeks of
age and over 50% died by 10 weeks of age (Fig. 2).
Gross anatomical examination of
SHIP
/
mice at 8-10 weeks of
age revealed, in addition to the pronounced splenomegaly, a uniform
enlargement and patchy whitish discoloration of the pleural surfaces of
the lungs compared to littermate controls (Fig. 3A).
Histologic examination revealed a massive infiltration of the air
spaces with distended lipid-laden macrophages, many of which were
multinucleated (Fig. 3B,C). The histiocytic origin of these cells was
corroborated by strong chloracetate esterase staining (Fig. 3D). The
infiltrates were located primarily in alveolar spaces in the pattern of
lipoid pneumonia. In addition, collections of neutrophils were
distributed throughout the consolidated areas, and in some sections
neutrophils were present in bronchiolar lumens. Although the degree of
lung involvement was extensive and became progressively pronounced with
age, the infiltrates were somewhat patchy in that areas of normal lung
could be found adjacent to abnormal areas (Fig. 3B). Stains for
bacteria and fungi were negative, and serological testing showed no
evidence of viral pathogens or mycoplasma, ruling out obvious
infectious causes. Similar lung histopathology was observed in the
second line of SHIP
/
mice
generated and housed in a separate pathogen-free animal facility (not shown).
|
|
Numerous hemopoietic abnormalities are observed in
SHIP
/
mice
Because SHIP is believed to play an important role in the
hemopoietic system, various hematological parameters of these mice were
examined. No significant abnormalities were observed in hematocrits, peripheral blood white cell counts, or peripheral blood red cell counts. However, differential counts of peripheral blood smears revealed a substantial increase in the percentage of circulating monocytes and mature neutrophils with a concomitant decrease in the
percentage of circulating lymphocytes (Table 2).
Cytospins of bone marrow from
SHIP
/
mice showed a similar
increase in mature neutrophils, with a reduction in lymphoid and late
erythroid cells (not shown).
|
Flow cytometric analysis of selected hemopoietic organs was carried
out to further characterize the nature of the hemopoietic perturbations in the SHIP
/
mice. The percentage of cells staining positive for both Mac-1 and
Gr-1 (Mac-1+Gr-1+), representing monocytes and granulocyte
progenitors, was significantly elevated [1.69 ± 0.16-fold
(P = 0.005; n = 5) above
+/+ littermates] in the marrow of
SHIP
/
mice (Fig. 4A, upper
panel). In contrast, significant reductions in the
percentage of bone marrow cells expressing the B220 antigen were
noted (Fig. 4A, middle panel). In 8-10-week-old
SHIP
/
mice the percentage of
B220bright cells was reduced to ~20% of wild-type levels
(5.03 ± 0.58% for wild type vs. 0.95 ± 0.12% for
SHIP
/
; P = 0.005;
n = 3). Similarly, the percentage of bone marrow Ter119-positive erythroid cells was decreased to 70.0 ± 5.7% of wild-type levels in the 4-week-old animals (Fig. 4A, lower panel). The
marrow erythroid component was reduced to 30% of normal
(31.29 ± 4.94% Ter119+ for +/+ compared to
10.16 ± 1.92% for SHIP
/
;
n = 3; P = 0.03) by 8-10 weeks of age. Because
the bone marrow cellularity (Table 1), as well as the percentages of
B220+ and Ter119+ cells, are reduced in these older
SHIP
/
mice, total numbers of
B-lymphoid and late erythroid cells are significantly reduced in the
marrow compartment. In contrast, when the increased percentage of
Mac-1+Gr-1+ cells is examined in the context of the decreased
marrow cellularity, absolute numbers of these cells are not
significantly different in the
SHIP
/
mice compared to their
+/+ littermates. Results of phenotypic analysis of
bone marrow cells derived from +/
mice were
similar to those of the wild-type cells (not show).
|
Representative FACS profiles from the analysis of splenic cells
isolated from 4-5-week-old littermates are presented in Figure 4B. At
this age there are no significant differences in the percentages of
cells that are Mac-1+Gr-1+, B220+, or Ter119+ in the
SHIP null mice (n = 5). However, because spleen
cellularity of SHIP
/
mice is
increased twofold relative to +/+ mice (Table 1),
absolute numbers of cells expressing each of these markers are elevated ~twofold. In spleens from 8-10-week-old
SHIP
/
mice there are almost
4.5 times as many Mac-1+Gr-1+ cells (6.0 ± 0.2% in
+/+ compared with 26.2 ± 5.3% for
SHIP
/
; n = 3;
P = 0.03). This translates into a 12-fold increase in absolute numbers of granulocyte progenitors and monocytes when the
increased spleen cellularity is considered.
Normal proportions of CD4 and CD8 single-positive, double-positive, and
double-negative thymocytes were seen in
SHIP
/
mice at both 4-5 weeks
of age (Fig. 4C) and 8-10 weeks of age (not shown). FACS analysis of
peripheral blood cells revealed an increased percentage of
Mac-1+Gr-1+ cells and a decreased percentage of cells expressing
the B220 antigen (not shown). Thus, the FACS data are consistent with
the changes observed in the counts of peripheral blood smears (Table 2).
SHIP
/
mice have decreased lymphoid
and increased myeloid progenitor numbers
In order to determine if these perturbations in the hemopoietic
organs and peripheral blood arise at the progenitor level, bone marrow
cells from SHIP+/+,
SHIP+/
, and
SHIP
/
mice were plated in
methylcellulose-based media and various assays performed. Absolute
numbers of clonogenic progenitors observed with +/
cells were similar to wild-type levels (data not shown). Numbers of
pre-B lymphoid (Fig. 5A) colony-forming cells were reduced to 39% of
normal in mice 4-5 weeks of age, whereas numbers of day 2 colony-forming unit-erythroid (CFU-E) (Fig. 5B) progenitors were
reduced to 47% of the levels observed in +/+
littermates. In both cases the reduction in
progenitor numbers was more pronounced in animals 8-10 weeks of age.
Neither day 3 burst forming unit (BFU)-erythroid nor day 10 BFU-E
progenitor numbers were significantly reduced (results not shown),
suggesting a block in the late stages of erythroid maturation. Although
slight increases were observed in the number of granulocyte-macrophage
colony forming cells (CFC) in
SHIP
/
bone marrow (Fig. 5C),
dramatic elevations were seen in the spleen (Fig. 5D). For example, CFC
numbers were elevated almost 70-fold in the spleens of
SHIP
/
mice 8-10 weeks of age.
We observed similar increases in numbers of CFC-GM, and decreases in
CFU-E, using the SHIP
/
ES cells in an
in vitro differentiation system (not shown) suggesting that these
variations in differentiation potential are intrinsic to the progenitor cells.
|
Hemopoietic progenitors lacking SHIP are hyper-responsive to multiple cytokines
The generation and maturation of CFC can be achieved both in vitro
and in vivo using a number of different growth factors. We therefore
examined the colony-forming ability of
SHIP
/
bone marrow cells in
methylcellulose-based media containing various concentrations of
cytokines that play a role in myeloid development. Under these
conditions, SHIP
/
bone marrow
progenitors exhibited an enhanced sensitivity to all growth factors
examined (Fig. 6). Both GM-CSF (Fig. 6A) and IL-3
(Fig. 6B) yielded 50% maximal colony formation at a 10-fold lower
concentration using SHIP
/
cells
compared to those of +/+ and
+/
littermates. These observations were confirmed
using bone marrow derived from a second, independently derived line of
SHIP null mice (not shown). In addition,
SHIP
/
bone marrow cells were
some two- to threefold more sensitive to SF (Fig. 6C) and M-CSF (Fig. 6D).
|
In an attempt to determine if the absence of SHIP influenced colony
size, suspension cultures were established with
SHIP+/+ or
SHIP
/
bone marrow cells in the
presence of 0.01 ng/ml GM-CSF or 1.0 ng/ml
IL-3 under conditions similar to those used to assess colony formation.
SHIP
/
cultures yielded more
cells in the presence of either GM-CSF or IL-3 than littermate control
cultures. Moreover, if the cell yields from these suspension cultures
were divided by the number of colonies generated in methylcellulose, it
appears that the GM-CSF-stimulated
SHIP
/
colonies were
approximately double the size of those generated by the wild-type
cells. In contrast, no difference in colony size was observed in the
presence of IL-3.
Growth-factor-independent colony formation is one property of certain
transformed cell populations. In order to evaluate the possibility that
SHIP
/
progenitors possessed
such potential, cells from all three genotypes of mice were plated in
methylcellulose-based media containing 15% serum, but no growth
factors. No colonies greater than 20 cells were observed in cultures
from the wild-type, heterozygous, or SHIP null mice. However,
51.0 ± 3.9% of the SHIP
/
CFC detectable in cytokine-containing media were capable of giving rise
to small clusters ranging in size from 5-20 cells. No such clusters
were observed using cells from +/+ or
+/
mice, suggesting that
SHIP
/
progenitors exhibit
enhanced survival, but only minimal proliferation, in the absence of
exogenous growth factors.
| |
Discussion |
|---|
|
|
|---|
Tyrosine phosphorylation of SHIP is an early response to
stimulation of many hemopoietic cell-surface receptors (Cutler et al.
1993
; Damen et al. 1993
; Lioubin et al. 1994
). SHIP has been demonstrated to play a major role in Fc
RIIB inhibitory signaling in both B cells (Ono et al. 1997
) and mast cells (Ono et al. 1996
). Thus, it has been postulated that SHIP may play a central role in negatively regulating the responses of both primitive and mature hemopoietic cells to external stimuli. We now demonstrate that the
absence of SHIP in vivo results in a marked pathology exemplified by a
shortened lifespan, pronounced splenomegaly, and massive myeloid cell
accumulations in the lungs.
One of the most striking features of
SHIP
/
mice was the decreased
life span, with death observed as early as 4 weeks of age and only 40%
of the animals surviving 14 weeks. We observed no major abnormalities
in hematoxylin and eosin (H&E) stained sections of the brain, liver, or
kidney (results not shown). In addition, peripheral blood abnormalities
such as anemia, increased numbers of blast cells, or grossly elevated
white cell counts were not seen. Thus, the most likely explanation for
the early death of SHIP
/
mice
would appear to be gross impairment of lung function caused by myeloid
cell infiltration. Interestingly, some mice have now survived as long
as six months, although they do exhibit decreases in body weight and a
"scruffy" appearance. The variability in life span is most likely
caused by the mixed genetic background inherent in the F2
populations examined in this study.
Phenotypically, SHIP
/
mice
bear some resemblance to normal mice transplanted with bone marrow
cells engineered for retroviral-mediated overexpression of GM-CSF.
Splenomegaly, reductions in bone marrow cellularity, and patchy
consolidation of the lungs, as well as decreased numbers of bone marrow
erythroblasts and lymphocytes, were observed in these transplanted mice
(Johnson et al. 1989
). SHIP
/
mice also exhibit marked increases in the numbers of
granulocyte-macrophage progenitors in the bone marrow, and especially
the spleen. These increases are associated with an enhanced sensitivity
of SHIP
/
granulocyte-macrophage progenitors to multiple cytokines including IL-3, GM-CSF, M-CSF, and SF. In this regard, we have also observed an
enhanced degranulation of
SHIP
/
bone-marrow-derived mast
cells in response to IgE, suggesting that SHIP plays a major
role in setting the threshold for cellular responses to external
stimuli (M. Huber, C.D. Helgason, J.E. Damen, L. Liu, R.K. Humphries,
and G. Krystal, in prep.). Because the lungs are a major site of GM-CSF
production (Tazi et al. 1993
) and
SHIP
/
CFC exhibits a 10-fold
increase in sensitivity to this cytokine, this may be sufficient to
account for the abnormal accumulations of myeloid cells in the lung.
SHP-1, a protein-tyrosine phosphatase expressed primarily in
hemopoietic cells (Yi et al. 1992
), has been implicated as a negative
regulator of signal transduction (Shultz et al. 1997
). Mice homozygous
for the mutated motheaten (Hcphme) or viable motheaten
(Hcphme-v) alleles exhibit enhanced proliferation of
monocyte/macrophage progenitors, splenomegaly, and a
fatal hemorrhagic pneumonitis associated with accumulations of
macrophages, granulocytes, and lymphocytes in the lungs (Tsui and Tsui
1994
). Absence of functional SHP-1 increases the proliferative response
of macrophages from these mice to GM-CSF (Jiao et al. 1997
), leading to
the suggestion that deregulated proliferation of myeloid cells may
account for the phenotype of these mice.
The similarities between the phenotypes of
SHIP
/
and viable motheaten
mice raise an important question regarding the relative importance of
SHIP and SHP-1 in negatively regulating cytokine signaling. That is, do
these molecules function independently, within the same pathway, or in
an overlapping manner? Studies using homologous recombination in the
chicken DT-40 cell line suggest that SHP-1 and SHIP function
independently in response to signaling through different receptors (Ono
et al. 1997
). For example, signals initiated by the killer cell
inhibitory receptor are mediated by SHP-1, but not SHIP. Conversely,
the proapoptotic signals initiated by Fc
RIIB signaling are
attenuated by SHIP but not SHP-1, suggesting that
SHIP
/
mice should exhibit
B-lymphoid perturbations. In fact, we observe decreased percentages of
B220+ cells in the bone marrow and spleen of
SHIP
/
mice and pre-B
colony-forming cell numbers are significantly reduced. Further
phenotypic and functional analyses of the B-lymphoid populations are
currently in progress to evaluate the consequences of loss of
SHIP-mediated negative signaling.
Several signal transduction pathways may be involved in the enhanced
growth factor sensitivity of the
SHIP
/
progenitors. One
possible mechanism involves hyperactivation of the Ras pathway. SHIP
associates with the protein tyrosine phosphatase SHP-2 in response to
growth factors such as IL-3 and erythropoietin (Liu et al. 1997b
;
Sattler et al. 1997
). Because the activity of SHP-2 is postulated to
contribute to Ras-MAP kinase activation, association of SHIP with SHP-2
could modulate activity of the Ras pathway. In addition, SHIP may
compete with Grb2 for Shc, thereby regulating the levels of Shc-Grb2
association within the cell (Liu et al. 1994
; Tridandapani et al.
1997
). In either case, absence of SHIP could theoretically lead to
enhanced Ras activity. Although we have not yet examined the
phosphorylation of Shc or activation of the Ras pathway in
cytokine-stimulated bone marrow progenitors, studies with
IgE-stimulated SHIP
/
mast
cells suggest that Shc phosphorylation is markedly reduced compared to
IgE-stimulated SHIP+/+ mast cells (M. Huber, C.D. Helgason, J.E. Damen, L. Liu, R.K. Humphries, and G. Krystal, in prep.). Experiments are now in progress to examine these
biochemical pathways in more detail.
A second possible mechanism underlying the enhanced proliferative
potential of SHIP
/
granulocyte-macrophage progenitors resides in the phosphatase activity
of SHIP. The PI-3-K pathway plays an important role in signaling
through cytokine receptors. For example, PIP3 is capable of
stimulating members of the protein kinase C family (Toker et al. 1994
),
as well as modulating the activity of the Akt/PKB kinase (Marte and Downward 1997
). In the absence of SHIP, which metabolizes this PI-3-K product, uncontrolled activation of these pathways could
result in enhanced cell survival and proliferation.
In conclusion, we have provided evidence that supports the hypothesis
that SHIP is an important negative regulator of cytokine signaling in
cells of the hemopoietic system.
SHIP
/
mice provide a powerful
model in which to further explore SHIP function in hemopoietic stem and
progenitor cell compartments, as well as in mature cells. In addition,
studies with cells from these mice should further our understanding of
the molecular mechanisms by which signaling thresholds are established
in both mature cells and progenitors.
| |
Materials and methods |
|---|
|
|
|---|
SHIP gene targeting
A genomic DNA library derived from the 129 mouse strain was screened with a 600-bp fragment derived from the 5' end of the SHIP cDNA. Positive clones were analyzed by restriction mapping and sequence analysis. The targeting vector was engineered to contain a 254-bp ApaI-BamHI deletion, thus effectively removing the transcriptional start site and most of the first exon. A Tk-neo cassette derived from pMC1TkNeoPolyA was subcloned into the deletion site in the opposite transcriptional orientation. The targeting vector contains 1.8 kb of SHIP homologous 5' DNA and 6.0 kb of 3' SHIP genomic DNA. A second targeting vector was constructed to include the HSV-Tk gene from pMC1-Tk at the 3' end of the targeting sequence.
Each linearized targeting construct was electroporated into the R1 ES cell line and colonies were isolated following selection in either G418 alone or G418 plus gancyclovir. Genomic DNA was isolated from pools of 6-8 clones and analyzed by PCR analysis using Elongase (Life Technologies) to generate a 2662-bp amplicon derived from an internal Neo primer (5'-CAAGATGGATTGCACGCAGG) and a 5' SHIP primer (G3: 5'-CCAGAAGTGTCTCTATCATGATAGT). Positive colonies were expanded and purified genomic DNA was digested with KpnI and analyzed by Southern blot analysis using a 2-kb KpnI-HindIII genomic probe. By Southern analysis, the nontargeted SHIP allele and the positively targeted allele were visualized as 4.6- and 5.8-kb bands, respectively. One clone out of 300 was positive using the double-selection protocol, whereas 7 positive clones were obtained with the single-selection vector. Similar blots were also probed with a Neor fragment to confirm single integrations (results not shown).
Germ-line transmission chimeras of clone 4.8B (double-selection vector) and clone 5.1 (single-selection vector) were generated by injection of C57BL/6J blastocysts, followed by breeding onto a C57BL/6J background. Genotype analysis was routinely done using Southern blot analysis and the probe described above. Animals were housed in microisolator units and provided with sterilized food and water. Routine testing for viral pathogens and mycoplasma was carried out on both animal colonies in which the two independent lines were maintained.
Homozygous deletion SHIP ES cells were generated by gene
conversion in increasing concentrations of G418 using previously described techniques (Mortensen et al. 1992
). Southern blot analysis of
genomic DNA confirmed the absence of the SHIP allele.
Karyotype analysis was carried out on all clones used both in vitro and in vivo in this study.
Western blot analysis
Equivalent numbers of nucleated cells, derived from hemopoietic
suspension cultures of day 10 embryoid bodies (differentiated as
described previously; Helgason et al. 1996
) generated with SHIP wild-type, heterozygous, and null R1 ES cells, were
washed once in phosphate-buffered saline, solubilized with 1.0%
Triton-X 100 at 4°C, and subjected to Western blot analysis as
described previously (Damen et al. 1993
). Bone marrow cells from all
three genotypes of mice were treated in a similar manner. The SHIP
antibodies used for Western blot analysis were generated against the
SH2 domain and the region spanning the two NPxY motifs using GST fusion proteins as described previously (Liu et al. 1997a
).
Preparation of sections and slides
Selected organs were fixed in a buffered 4% paraformaldehyde solution, dehydrated in ethanol, and embedded in paraffin for sectioning. Sections were prepared and H&E stained at the Academic Pathology Laboratory, University of British Columbia, Vancouver using standard protocols. Cytospin preparations of bone marrow and spleen, as well as peripheral blood smears, were routinely stained with a modified Wright-Geimsa stain.
Assays to detect clonogenic progenitors
Nucleated cell counts were performed on bone marrow aspirates or cell suspensions of spleen, prepared using a nylon mesh screen. Appropriate cell numbers were plated in a 1.1 ml volume per Petri dish in standard conditions to detect the various clonogenic progenitors. All cell culture was carried out in a humidified incubator at 37°C with 5% CO2. Bone marrow pre-B progenitors were detected by culture in methylcellulose media containing 10 ng/ml IL7 for 5 to 7 days [StemCell Technologies Inc. (STI), Vancouver; Methocult M3630]. Methocult M3230 (STI) was supplemented with 50 ng/ml Steel factor (supplied as a supernatant from Cos cells engineered to express the protein) and 3 U/ml rhEpo for detection of day 2 CFU-E and day 3 BFU-E. Methocult M3434 (STI) containing 10 ng/ml rmIL-3, 10 ng/ml rhIL-6, 50 ng/ml rmSF, and 3 U/ml rhEpo was used for the detection of myeloid (CFC), late erythroid, and multipotential progenitors in bone marrow and spleen cell preparations. All colonies were scored microscopically using standard criteria.
Bone marrow cells derived from mice of all three genotypes were cultured in Methocult M3234 (STI) in the indicated concentrations of IL-3, rmGM-CSF (Peprotech), SF (supplied as a Cos supernatant), or rhM-CSF (Genetics Institute, Cambridge, MA) for growth factor response curves. Colonies containing 20 or more cells were scored. In all cases duplicate determinations were performed on each sample. Statistical significance compared with the +/+ populations was determined using the Student's t-test.
Flow cytometry
Bone marrow, spleen, thymus, or lymph node cells at a density of 5-10 × 106 cells/ml were incubated on ice for 30 min with 3 µg/ml 2.4G2 (murine anti-IgG Fc receptor antibody) followed by incubation on ice for 40 min with the various FITC-labeled or phycoerythrine-conjugated antibodies. Cells were washed twice in Hank's balanced salt solution containing 2% fetal bovine serum at 4°C and propidium iodide (Sigma Chemicals, St. Louis, MI) at a concentration of 1 ug/ml was included in the final wash. Cells were analyzed on a FACStar+ or FACSort (Becton-Dickinson, San Jose, CA).
The monoclonal antibodies used for analysis included: E13-161.7
(anti-Sca-1), RB6-8C5 (anti-Gr-1; granulocytes), M1/70
(anti-Mac-1; macrophages), Ter119 (anti-erythroid lineage) (the sources
of these antibodies have been described elsewhere; Rebel et al. 1996
). Antibodies against CD4, CD8, B220, and CD11b were purchased from Pharmingen (Mississauga, Ontario, Canada).
| |
Acknowledgments |
|---|
The authors thank James Ihle for helpful discussions regarding the targeting strategy. In addition, the authors wish to thank Gayle Thornbury and Giovanna Cameron for expert technical assistance on the FACStar+, Gloria Shaw for karyotype analysis of the ES clones, Malin Parmar for assistance with PCR and Southern blot analysis, and Julie Chow for preparation and staining of the lung sections, as well as Rosemary Hood, Christian Kalberer, Ling Liu, and Cindy Miller for helpful discussions. This work was supported by the National Cancer Institute of Canada (with funds from the Canadian Cancer Society and the Terry Fox Run) and the Medical Research Council of Canada.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
Received March 18, 1998; revised version accepted April 13, 1998.
5 Corresponding author.
E-MAIL keith{at}terryfox.ubc.ca; FAX (604) 877-0712.
| |
References |
|---|
|
|
|---|
RIIB-mediated inhibition of B cell antigen receptor activation.
J. Biol. Chem.
272:
20038-20043
RIIB.
Nature
383:
263-266[CrossRef][Medline].This article has been cited by other articles:
![]() |
J. L. Bishop, L. M. Sly, G. Krystal, and B. B. Finlay The Inositol Phosphatase SHIP Controls Salmonella enterica Serovar Typhimurium Infection In Vivo Infect. Immun., July 1, 2008; 76(7): 2913 - 2922. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Kamen, J. Levinsohn, A. Cadwallader, S. Tridandapani, and J. A. Swanson SHIP-1 Increases Early Oxidative Burst and Regulates Phagosome Maturation in Macrophages J. Immunol., June 1, 2008; 180(11): 7497 - 7505. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Roget, M. Malissen, O. Malbec, B. Malissen, and M. Daeron Non-T Cell Activation Linker Promotes Mast Cell Survival by Dampening the Recruitment of SHIP1 by Linker for Activation of T Cells J. Immunol., March 15, 2008; 180(6): 3689 - 3698. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Harris, R. V. Parry, J. Westwick, and S. G. Ward Phosphoinositide Lipid Phosphatases: Natural Regulators of Phosphoinositide 3-Kinase Signaling in T Lymphocytes J. Biol. Chem., February 1, 2008; 283(5): 2465 - 2469. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Ramshaw, M. A. Guthridge, F. C. Stomski, E. F. Barry, L. Ooms, C. A. Mitchell, C. G. Begley, and A. F. Lopez The Shc-binding site of the {beta}c subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesis Blood, November 15, 2007; 110(10): 3582 - 3590. [Abstract] [Full Text] [PDF] |